Dosimetric planning study of respiratory-gated volumetric modulated arc therapy for early-stage lung cancer with stereotactic body radiation therapy

Respiratory-gated VMAT has the potential to reduce the dose to normal lung when treating early-stage NSCLC with SBRT for tumor motion greater than 5 mm.